ConductScience.org, home

Paper39354529

Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery.

Wu J and 8 others. Mol Cancer, 2024. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery. Papers, record 39354529. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39354529

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery.
PubMed
Journal
Mol Cancer
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
7.79, provisional
iCite
Revised in PubMed
2026-09-22
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu JJunyu
2Tang GGuoyi
3Cheng CSChien-Shan
4Yeerken RRanna
5Chan YTYau-Tuen
6Fu ZZhiwen
7Zheng YCYi-Chao
8Feng YYibin
9Wang NNing

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Medicine, Chinese TraditionalMajor topic
Drugs, Chinese HerbalMajor topic
Drug DiscoveryMajor topic
Liver NeoplasmsMajor topic
Humans
Biliary Tract Neoplasms
Animals

Source PubMed

Download CSV of topics

References264

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137928255Genipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma.Int J Biol Sci2023https://conductscience.org/library/papers/37928255PubMed
222326673Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy.J Ethnopharmacol2012https://conductscience.org/library/papers/22326673PubMed
332242383Comparative efficacy and safety of Chinese herbal injections combined with transcatheter hepatic arterial chemoembolization in treatment of liver cancer: a bayesian network Meta-analysis.J Tradit Chin Med2020https://conductscience.org/library/papers/32242383PubMed
437806155Ginsenoside Rh2 and its octyl ester derivative inhibited invasion and metastasis of hepatocellular carcinoma via the c-Jun/COX2/PGE2 pathway.Phytomedicine2023https://conductscience.org/library/papers/37806155PubMed
531377293A polysaccharide from Huaier ameliorates cisplatin nephrotoxicity by decreasing oxidative stress and apoptosis via PI3K/AKT signaling.Int J Biol Macromol2019https://conductscience.org/library/papers/31377293PubMed
635397286Effect of kangai injection combined with platinum-based chemotherapy on the immune function of patients with advanced non-small-cell lung cancer: A meta-analysis.Phytomedicine2022https://conductscience.org/library/papers/35397286PubMed
735534947Ginsenoside Rh2 mitigates doxorubicin-induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer-bearing mice.Cell Prolif2022https://conductscience.org/library/papers/35534947PubMed
833354776Icaritin inhibits PD-L1 expression by Targeting Protein IκB Kinase α.Eur J Immunol2021https://conductscience.org/library/papers/33354776PubMed
936909174Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis.Front Pharmacol2023https://conductscience.org/library/papers/36909174PubMed
1033984593Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway.Phytomedicine2021https://conductscience.org/library/papers/33984593PubMed
1125207889Kanglaite injection combined with hepatic arterial intervention for unresectable hepatocellular carcinoma: a meta-analysis.J Cancer Res Ther2014https://conductscience.org/library/papers/25207889PubMed
1233990545Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma.Cell Death Dis2021https://conductscience.org/library/papers/33990545PubMed
1331427001HP-1 inhibits the progression of ccRCC and enhances sunitinib therapeutic effects by suppressing EMT.Carbohydr Polym2019https://conductscience.org/library/papers/31427001PubMed
1434838619A novel strategy to reveal clinical advantages and molecular mechanism of aidi injection in the treatment of pancreatic cancer based on network meta-analysis and network pharmacology.J Ethnopharmacol2022https://conductscience.org/library/papers/34838619PubMed
1529673791The effects of polysaccharides from Auricularia auricula (Huaier) in adjuvant anti-gastrointestinal cancer therapy: A systematic review and network meta-analysis.Pharmacol Res2018https://conductscience.org/library/papers/29673791PubMed
1638378644HMGB1 promotes mitochondrial transfer between hepatocellular carcinoma cells through RHOT1 and RAC1 under hypoxia.Cell Death Dis2024https://conductscience.org/library/papers/38378644PubMed
1722607709Down-regulation of the PI3K/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin.J Exp Clin Cancer Res2012https://conductscience.org/library/papers/22607709PubMed
1831872855Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis.Biosci Rep2020https://conductscience.org/library/papers/31872855PubMed
1938561768Cancer-derived exosomes as novel biomarkers in metastatic gastrointestinal cancer.Mol Cancer2024https://conductscience.org/library/papers/38561768PubMed
2039242496Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma.Mol Cancer2024https://conductscience.org/library/papers/39242496PubMed

See all 264 referencesDownload CSV of references

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
42891387Knowledge Mapping and Frontier Evolution of Traditional Medicine in Hepatocellular Carcinoma Research: A Bibliometric Analysis.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42891387PubMed
42890064
Survival outcomes of spleen-strengthening and dampness-eliminating traditional Chinese medicine granules combined with lenvatinib for unresectable hepatocellular carcinoma: a large-sample retrospective study based on electronic medical records.
Front Med (Lausanne)2026https://conductscience.org/library/papers/42890064PubMed
42878941Integrative therapy with Qinghao Biejia Decoction improves survival after resection of intrahepatic cholangiocarcinoma.J Mol Histol2026https://conductscience.org/library/papers/42878941PubMed
42857277Ginsenoside Rb1 From the Functional Food Panax ginseng Suppresses Pancreatic Cancer Progression via Macrophage Reprogramming Through the PI3K-AKT Pathway.Food Sci Nutr2026https://conductscience.org/library/papers/42857277PubMed
42794982Combining Selective Internal Radiation Therapy (SIRT) and Systemic Therapy in Intrahepatic Cholangiocarcinoma.Cancers (Basel)2026https://conductscience.org/library/papers/42794982PubMed
42677101Cordycepin ameliorates ischemia/reperfusion-induced acute kidney injury via inhibiting apoptosis and necroptosis.Iran J Basic Med Sci2026https://conductscience.org/library/papers/42677101PubMed
42577953TCM-Driven Circadian Modulation in Cancer: Engineering Spatiotemporal Drug Delivery for Precision Oncology.Int J Nanomedicine2026https://conductscience.org/library/papers/42577953PubMed
42455421Targeting SLC7A11 with Chinese Medicine for Tumor Ferroptosis Induction: From Molecular Mechanisms to Novel Precision Therapeutic Strategies.Chin J Integr Med2026https://conductscience.org/library/papers/42455421PubMed
42298665Ethnomedicinal plants used by Guoshan Yao minority communities in the foothills of Nanling Mountain, Guangdong, China.J Ethnobiol Ethnomed2026https://conductscience.org/library/papers/42298665PubMed
42293741Lipid nanoparticles and extracellular vesicles: emerging cell free therapeutic platforms for hepatobiliary cancers.Front Cell Dev Biol2026https://conductscience.org/library/papers/42293741PubMed
42266751Schisandrin A suppresses hepatocellular carcinoma and sensitizes to sorafenib via modulating retinol metabolism.Am J Cancer Res2026https://conductscience.org/library/papers/42266751PubMed
42192454Research advances in the application of betulinic acid for anti-inflammatory and anti-tumour therapy.Chin Med2026https://conductscience.org/library/papers/42192454PubMed
42163812Self-Assembly of Stimuli-Responsive Peptide Enhances Therapeutics by Specifically Disrupting Hepatocellular Carcinoma Lysosomes In Vivo.Adv Mater2026https://conductscience.org/library/papers/42163812PubMed
42141267Integrating Network Pharmacology and Experimental Validation to Elucidate the Role of Huaier in Attenuating Liver Fibrosis via the AKT Signalling Pathway.Clin Exp Med2026https://conductscience.org/library/papers/42141267PubMed
42042068Natural Products in Endometrial Cancer: Molecular Mechanisms, Preclinical Evidence, and Clinical Perspectives.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42042068PubMed
41993589Bioactive plant and fungal metabolites in oral cancer: molecular mechanisms and translational potential.Front Pharmacol2026https://conductscience.org/library/papers/41993589PubMed
41929489Dual role of icaritin in attenuating allograft rejection and exerting antitumor effects in mice.Front Immunol2026https://conductscience.org/library/papers/41929489PubMed
41909727Targeting MEK2 by paeoniflorin: Mechanism underlying its protection against hypobaric hypoxia-induced lung injury.Acta Pharm Sin B2026https://conductscience.org/library/papers/41909727PubMed
41668791Machine learning-driven optimization of extraction process and development of quality standards for traditional Chinese medicine (TCM) formulae in primary liver cancer.RSC Adv2026https://conductscience.org/library/papers/41668791PubMed
41629743Gut microbial ammonia as a mediator of PFOS neurotoxicity and its remediation by the flavonoid Icaritin.Gut Microbes2026https://conductscience.org/library/papers/41629743PubMed

See all 35 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39354529

GET https://conductscience.org/api/papers/v1/39354529/references?page=2